Cybin Inc. to Participate in TD Cowen's 5th Annual Neuropsychiatry & Epilepsy Summit

Reuters
2025.09.11 11:30
portai
I'm PortAI, I can summarize articles.

Cybin Inc. will participate in TD Cowen’s 5th Annual Neuropsychiatry & Epilepsy Summit on September 17, 2025, at 9:20 a.m. ET. The company's Chief Medical Officer, Amir Inamdar, and Chief Business Officer, George Tziras, will engage in a fireside chat during the event. A webcast and replay will be available on the investor relations website.

Cybin Inc., a clinical-stage breakthrough neuropsychiatry company, is set to participate in TD Cowen’s 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit. The event will take place on Wednesday, September 17, 2025, at 9:20 a.m. ET. Amir Inamdar, Cybin’s Chief Medical Officer, and George Tziras, Cybin’s Chief Business Officer, will join a fireside chat during the summit. A webcast and replay will be available on the Company’s investor relations website. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cybin Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250911135365) on September 11, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)

Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.